Oxford Asset Management’s AbbVie ABBV Stock Holding History

Oxford Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-8,856	Closed	-$1.64M	–	428
2025 Q2	$1.64M	Buy	+8,856	New	+$1.65M	0.54%	22
2024 Q1	–	Sell	-3,418	Closed	-$530K	–	256
2023 Q4	$530K	Buy	+3,418	New	+$498K	0.79%	36
2020 Q1	–	Sell	-11,492	Closed	-$1.02M	–	209
2019 Q4	$1.02M	Sell	11,492 -83,617	-88%	-$6.94M	0.03%	851
2019 Q3	$7.2M	Sell	95,109 -28,181	-23%	-$1.93M	0.17%	156
2019 Q2	$8.97M	Buy	123,290 +91,874	+292%	+$7.22M	0.19%	121
2019 Q1	$2.53M	Buy	+31,416	New	+$2.57M	0.06%	464
2018 Q4	–	Sell	-20,401	Closed	-$1.93M	–	1749
2018 Q3	$1.93M	Sell	20,401 -35,468	-63%	-$3.36M	0.04%	683
2018 Q2	$5.2M	Sell	55,869 -31,441	-36%	-$3.07M	0.1%	224
2018 Q1	$8.26M	Buy	87,310 +74,739	+595%	+$8.21M	0.17%	100
2017 Q4	$1.23M	Buy	12,571 +7,444	+145%	+$702K	0.03%	831
2017 Q3	$455K	Sell	5,127 -57,648	-92%	-$4.39M	0.01%	1227
2017 Q2	$4.55M	Sell	62,775 -18,855	-23%	-$1.27M	0.09%	231
2017 Q1	$5.32M	Buy	+81,630	New	+$5.13M	0.13%	140

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oxford Asset Management's ABBV Position: Q3 2025 in Review

Oxford Asset Management sold out of AbbVie (ABBV) in Q3 2025, closing a stake of 8,856 shares — an estimated $1.64M sold.

Oxford Asset Management first reported a position in ABBV in Q1 2017 and held it in 13 quarters. The position peaked at $8.97M in Q2 2019. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

Oxford Asset Management reported no remaining AbbVie position as of Q3 2025 after selling out during the quarter.
Oxford Asset Management sold 8,856 AbbVie shares in Q3 2025, an estimated $1.64M.
Oxford Asset Management first reported a position in AbbVie in Q1 2017 and held it in 13 quarters.
Oxford Asset Management's AbbVie position peaked at $8.97M in Q2 2019.
3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Oxford Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.